Natural killer T (NKT) cells and their role in antitumor immunity

Critical Reviews in Oncology/Hematology

Volumn 41, Issue 3, 2002, Pages 287-298

  Brutkiewicz, Randy R ^a,b   Sriram, Venkataraman ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTHER CANCER INSTITUTE   (United States)

Author keywords

Antitumor; CD1; Cytokines; Glycolipids; IL 12; NKT cells

Indexed keywords

CD1 ANTIGEN; CD40 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLYCOLIPID; INTERLEUKIN 12; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOSPHOLIPID; TUMOR NECROSIS FACTOR; CD1D ANTIGEN;

ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CELL FUNCTION; CELL INTERACTION; CELL STIMULATION; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CYTOTOXICITY; HYBRIDOMA; IMMUNE RESPONSE; IMMUNITY; INFECTION; NATURAL KILLER CELL; NONHUMAN; PROTEIN BINDING; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TUMOR CELL; HUMAN; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; NEOPLASM;

ANTIGENS, CD1; CYTOKINES; HUMAN; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; NEOPLASMS; T-LYMPHOCYTES; HUMANS;

EID: 0036008999     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(01)00198-6     Document Type: Review

References (137)

1. Natural' killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype
2. 'Natural' killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell
3. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity
4. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells
5. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
6. In search of the 'missing self': MHC molecules and NK cell recognition
7. Natural killer cells in viral infection
8. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
9. Natural killer cells and cancer
10. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes
11. The biochemistry and cell biology of antigen processing and presentation
12. A novel population of T-cell receptor ab-bearing thymocytes which predominantly expresses a single Vb gene family
13. + subset
14. + T-cell antigen receptor a chain in mice
15. Selective reduction of T cells bearing invariant Vα24 JαQ antigen receptor in patients with systemic sclerosis
16. - T cells
17. + thymocytes selected by MHC class I molecules
18. + T cells by non-major histocompatibility complex-encoded class I-like molecules expressed on bone marrow-derived cells
19. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3
20. + T cells in a TH2 response and in immunoglobulin E production
21. + T cells that promptly produce interleukin 4
22. + T lymphocytes
23. 2-microglobulin-dependent surface expression of functional mouse CD1.1
24. CD1: From structure to function
25. The CD1 family: A third lineage of antigen-presenting molecules
26. Mouse CD1 is mainly expressed on hemopoietic-derived cells
27. + T cells by CD1-expressing cortical thymocytes
28. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4
29. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells
30. + T cell development and early IL-4 production in CD1-deficient mice
31. Tissue-specific segregation of CD1d-dependent and CD1d-independent NKT cells
32. NKT cells are phenotypically and functionally diverse
33. +NKT cells
34. + T cells
35. + T cells expressing NK cell receptors in influenza A virus-infected mice
36. + T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo
37. +NKT cells to the liver
38. CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients
39. + T cells coexpressing the inhibitory major histocompatibility complex class I receptor Ly49G2
40. The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids
41. Natural ligand of mouse CD1d1: Cellular glycosylphosphatidylinositol
42. Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove
43. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells
44. Cutting edge: The IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: Exploring the role of GPIs in NKT cell activation and antimalarial responses
45. Murine CD1d-restricted T cell recognition of cellular lipids
46. + NKT lymphocytes
47. Murine natural killer T (NKT) cells contribute to the granulomatous reaction caused by mycobacterial cell walls
48. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides
49. Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules
50. Structure-activity relationship of α-galactosylceramides against B16-bearing mice
51. KRN7000, a novel immunomodulator, and its antitumor activities
52. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors
53. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells
54. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution
55. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells
56. NKT cells: Facts, functions and fallacies
57. Mouse CD1-specific NK1 T cells: Development, specificity, and function
58. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers
59. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers
60. + T cells preferentially accumulate in human liver
61. + natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns
62. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice
63. Anti-asialo GM1 eliminates both inflammatory process and cytotoxic T-cell function in the lymphocytic choriomeningitis adoptive transfer model
64. Differential expression of the ASGM1 antigen on anti-reovirus and alloreactive cytotoxic T lymphocytes (CTL)
65. Mechanism of anti-asialo GM1 prevention of graft-vs-host disease: Identification of allo-antigen activated T cells
66. + T cells as novel interleukin-12-responsive killer T cell precursors
67. Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice
68. Cloning and functional characteristics of murine large granular lymphocyte-1: A member of the Ly-49 gene family (Ly-49G2)
69. + T cells in major histocompatibility complex class II-deficient mice
70. Diverse TCRs recognize murine CD1
71. The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families
72. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography
73. Phenotypic analysis of antigen-specific T lymphocytes
74. Interleukin-12: A cytokine at the interface of inflammation and immunity
75. Cytokines in the generation of immune responses to, and resolution of, virus infection
76. Cutting edge: Selective IL-18 requirements for induction of compartmental IFN-γ responses during viral infection
77. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration
78. Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection
79. IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses
80. + T cells in IL-12-induced immune responses in vivo
81. + αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis
82. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12
83. + αβ T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells
84. Antitumor effect of α-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver
85. Potentiation of antitumor effect of NKT cell ligand, α-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells
86. Adhesion mediated by LFA-1 is required for efficient IL-12-induced NK and NKT cell cytotoxicity
87. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1
88. A distinct IL-18-induced pathway to fully activate NKT lymphocytes independently from TCR engagement
89. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: A pro-Th2 effect of IL-18 exerted through NKT cells
90. Fas/Fas ligand interactions promote activation-induced cell death of NKT lymphocytes
91. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis
92. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells
93. Rapid death and regeneration of NKT cells in anti-CD3ε- or IL-12-treated mice: A major role for bone marrow in NKT homeostasis
94. + T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells
95. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
96. Natural killer T cell activation inhibits hepatitis B virus replication in vivo
97. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide
98. Role of early cytokines, including alpha and beta interferons (IFN-α/β), in innate and adaptive immune responses to viral infections
99. + T cell immunity
100. The CD40-CD154 system in anti-infective host defense
101. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
102. + NKT cells and antigen-presenting cells
103. The natural killer T (NKT) cell ligand a-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells
104. +NKT cells: Stimulation of IL-12 production by antigen-presenting cells in the innate immune system
105. The interface between innate and acquired immunity: Glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes
106. IL-12 up-regulates CD40 ligand (CD154) expression on human T cells
107. + T cells as well as NK cells against intraperitoneal tumors in mice
108. Differential tumor surveillance by natural killer (NK) and NKT cells
109. Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12
110. The anti-tumor activity of IL-12: Mechanisms of innate immunity that are model and dose dependent
111. Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Vα14 NKT cells
112. Synergistic suppressive effect of double transfection of tumor necrosis factor-α and interleukin 12 genes on tumorigenicity of Meth-A cells
113. The critical role of Th1-dominant immunity in tumor immunology
114. + T cells upon NKT or T cell activation
115. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4-STAT6 pathway
116. Membrane lymphotoxin is required for the development of different subpopulations of NKT cells
117. Requirement for membrane lymphotoxin in natural killer cell development
118. + T cells from IL-7-deficient mice have a normal distribution and selection but exhibit impaired cytokine production
119. + T cell-defective IL-4 production in the non-obese diabetic mouse
120. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation
121. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice
122. Crispe IN. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cell
123. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18
124. Regulation of immune responses through inhibitory receptors
125. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
126. Generation of cellular immunity to lymphocytic choriomeningitis virus is independent of CD1d1 expression
127. + T cell interactions in IFN-γ and IL-4 responses to viral infections: Requirements for IL-2
128. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
129. Human NKT cells mediate anti-tumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells
130. +) T cells established from murine tumor-infiltrating lymphocytes
131. Immune suppression and skin cancer development: Regulation by NKT cells
132. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells
133. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction
134. Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: Non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect
135. + T cells reciprocally regulate acute graft versus host disease
136. + natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon γ production
137. CD1d and natural T cells: How their properties jump-start the immune system